What is Precision BioSciences Inc?
, a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 282.46M, and a P/E ratio of 29.6x.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 12,821 shares $28k | 34,744 shares $30k |
| 3-6months | 0 | 0 |
| 6-9months | 0 | 0 |
| 9-12months | 8107,624 shares $431k | 37,081 shares $34k |